Ann: Appointment of CEO, page-32

I am a recent UBI shareholder, having purchased shares following the announcement that John Sharman would be appointed CEO of the company commencing 1st of July 2020.

Scharman's track record at Medical Developments International (MVP:ASX) was incredible and clearly he is looking to repeat that success at UBI. For anyone that is interested take a look at the 10 year chart of MVP (below) and you won't be disappointed. Also worth noting that he was managing director of private equity firm CVC Venture Managers (who currently hold 23.8 million shares - 13.41% of the company).

Let's look at who has joined the register recently:

- JM Financial Group amassed just under 3 million shares and they were one of the big early shareholders in MVP
- A company associated with David Williams, current chairman of MVP.

Not long now, so who has been selling?

The main sellers have been former employees of UBI who have left the company. clearly not interested in holding stock.

I'm sure lots of cost cutting has been occurring at UBI and I wouldn't be surprised to see a merger/acquisition in the pipeline in the near future. Now is the time to accumulate while there is some loose stock around. The top 20 shareholders control approx 70% of the stock, so any gains are going to be magnified.